We propose a study to determine the single-dose pharmacokinetics of these two novel
formulations of testosterone in normal men with experimentally induced hypogonadism.
Phase:
Phase 1
Details
Lead Sponsor:
University of Washington
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institutes of Health (NIH)